About Nanosphere
Nanosphere is a company based in Northbrook (United States) founded in 1999 was acquired by Luminex in May 2016.. Nanosphere has raised $97.75 million across 11 funding rounds from investors including NIH, Luminex Corporation and Takara Bio. The company has 146 employees as of December 31, 2016. Nanosphere operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Northbrook, United States
- Employees 146 as on 31 Dec, 2016
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanosphere, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Sales and Marketing
18 people
Software Development Team
11 people
Finance and Accounting
10 people
Human Resources and Administration
8 people
Corporate Team
4 people
Senior Team
4 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Nanosphere
Nanosphere has successfully raised a total of $97.75M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $970.97 thousand completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $970,967
-
First Round
First Round
(01 Mar 2000)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Post-IPO - Nanosphere | Valuation |
investors |
|
| May, 2015 | Amount | Debt – Conventional - Nanosphere | Valuation |
investors |
|
| Mar, 2010 | Amount | Grant - Nanosphere | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanosphere
Nanosphere has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Luminex Corporation and Takara Bio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investments and advisory services are provided by the holding company.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanosphere
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanosphere
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanosphere Comparisons
Competitors of Nanosphere
Nanosphere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are provided through laboratories and radiology units.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanosphere
Frequently Asked Questions about Nanosphere
When was Nanosphere founded?
Nanosphere was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Where is Nanosphere located?
Nanosphere is headquartered in Northbrook, United States. It is registered at Northbrook, Illinois, United States.
Is Nanosphere a funded company?
Nanosphere is a funded company, having raised a total of $97.75M across 11 funding rounds to date. The company's 1st funding round was a Grant of $279K, raised on Mar 01, 2000.
How many employees does Nanosphere have?
As of Dec 31, 2016, the latest employee count at Nanosphere is 146.
What does Nanosphere do?
Nanosphere was founded in 1999 and is based in Northbrook, United States. Diagnostic tests for personalized medicine are developed and supplied, with a focus on infections in the bloodstream, respiratory tract, and gastrointestinal tract. The Verigene System is employed, incorporating automation and proprietary chemistry for direct nucleic acid and protein detection on a single platform. All tests are constructed using gold nanoparticle probe technology within the healthcare diagnostics sector.
Who are the top competitors of Nanosphere?
Nanosphere's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
Who are Nanosphere's investors?
Nanosphere has 10 investors. Key investors include NIH, Luminex Corporation, Takara Bio, Allen & Company, and SWK Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.